title: Percutaneous placement of femoral central venous catheter in patients undergoing transplantation of bone marrow.
abstract: Five patients undergoing transplantation of autologous bone marrow underwent percutaneous placement of a double lumen central venous catheter into the inferior vena cava by way of the femoral vein. All had conditions that precluded access to the superior vena cava or other sites in the upper part of the torso. Patients ranged in age from 18 to 59 years. The double lumen central venous catheter was inserted using aseptic technique in the operating room, and the catheter exit site was dressed using sterile technique every 48 hours afterward. Patients received all irradiated blood product transfusions, intravenous fluids, intravenous antibiotics, parenteral alimentation and autologous bone marrow reinfusion through the catheter. The duration of severe neutropenia (less than 500 neutrophils per microliter) and severe thrombocytopenia (less than 20,000 platelets per microliter) ranged from zero to 24 days (median of 22 days) and five to 20 days (median of 15 days), respectively. Catheters remained in the groin area 23 to 45 days (median of 35 days). Complications included one catheter-related Streptococcus species infection and one Escherichi coli bacteremia. These infections resolved with the catheter in place after appropriate institution of antibiotics. No episodes of thrombosis, kinking, migration, extravasation of drugs or local infection were noted. Central venous catheters can be safely inserted and maintained in the groin area even in severely immunocompromised patients receiving bone marrow transplants.
authors.affiliation: Department of Medicine, Ireland Cancer Center, University Hospitals of Cleveland, Case Western Reserve University, Ohio.
authors.forename: H M
authors.initials: HM
authors.lastname: Lazarus
authors.forename: R J
authors.initials: RJ
authors.lastname: Creger
authors.forename: A D
authors.initials: AD
authors.lastname: Bloom
authors.forename: R
authors.initials: R
authors.lastname: Shenk
mesh_terms: D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation; D002405:Catheterization, Central Venous / Q000009:adverse effects / Q000379:methods*; D002408:Catheters, Indwelling / Q000009:adverse effects; D004927:Escherichia coli Infections / Q000209:etiology; D005069:Evaluation Studies as Topic; D005260:Female; D005268:Femoral Vein; D006801:Humans; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000209:etiology; D018805:Sepsis / Q000209:etiology; D012826:Silicone Elastomers; D013290:Streptococcal Infections / Q000209:etiology; D013997:Time Factors; D014182:Transplantation, Autologous
chemical_list: D012826:Silicone Elastomers